TrialAnnals of the rheumatic diseases2016

Value of ultrasonography as a marker of early response to abatacept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results from the APPRAISE study.

Maria-Antonietta D'Agostino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.